Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Neurology
»
Parkinson
16. December 2025
Search
medline.ch
Parkinson
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2792
Articles 1 - 20 / 55827
Assessing Gastrointestinal Motility in Caenorhabditis elegans RAC1/CED-10 Mutants as a Tool to Study Early Parkinson's Disease.
J Vis Exp
Muñoz-Juan A, Laromaine A, Yuste VJ, Dalfó E.
PMID: 41396855 [PubMed - indexed for MEDLINE]
Physical Exercise and Survival in Parkinson's Disease: A Cohort Study.
Res Q Exerc Sport
Gil PR, da Silveira J, Borgatto AF, Moratelli JA, Sonza A, Coutinho de Azevedo Guimarães A.
PMID: 41396816 [PubMed - as supplied by publisher]
Investigating the Effectiveness of Haptic Resistive Force Feedback to Improve Tremors in Parkinson's Disease: A Training Impact Study.
IEEE J Biomed Health Inform
Mahmood N, Bektic M, Li C, Ridgel A, Kim K.
PMID: 41396751 [PubMed - as supplied by publisher]
Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer's and Parkinson's diseases.
Redox Rep
Simão S, Santos DF, Teixeira M, Agostinho RR, Rodrigues J, Vitorino M, Araújo IM.
PMID: 41396689 [PubMed - indexed for MEDLINE]
Editorial: Advancing personalized diagnosis and treatment in Parkinson's disease: integrating biomarkers, neuroimaging, and artificial intelligence.
Front Neurosci
Giani AM, Shafeek S, Tatti E.
PMID: 41395265 [PubMed]
Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy.
MedComm (2020)
Guo XY, Song DY, Wu MY, Zhang JQ, Li JY, Yuan L.
PMID: 41394959 [PubMed]
Validation of an aspiration risk prediction model for Parkinson's disease based on nomogram: a single-center study.
PeerJ
Xu YY, Wei Y, Sha L.
PMID: 41394422 [PubMed - indexed for MEDLINE]
The left DTI-ALPS index: a potential glymphatic mediator of cognitive and motor dysfunction in Parkinson's disease.
Front Med (Lausanne)
Li Y, Song J, Zhao Y, Lin Z, Pan X, Li M, Zhou X, Zhang Z, Wei W, Xue X.
PMID: 41393121 [PubMed]
Development and emerging trends in gastrointestinal dysfunction of Parkinson's disease: a decade-long bibliometric analysis.
Front Aging Neurosci
Sun Y, Yang H, Zhang J, Cong S, Wang L, Yu T.
PMID: 41393108 [PubMed]
Effects of inspiratory muscle training on upper and lower extremity functional exercise capacity, muscle oxygen, and cough strength in patients with Parkinson's disease.
Physiother Theory Pract
Güne, Bo, Güvenir A, Bora Tokçaer A.
PMID: 41392483 [PubMed - as supplied by publisher]
Glymphatic dysfunction in Parkinson's disease: Aging-associated impairments, imaging biomarkers, and therapeutic strategies.
Ageing Res Rev
Lv Y, Ding XS, Gao L, Han Z, Feng CX, Li YN, Wang YF, Yang Q, Simon DK, Wang XL, Qu Y, Wang B.
PMID: 41391512 [PubMed - as supplied by publisher]
The impact of loneliness on balance learning ability in aging patients with Parkinson's disease.
BMC Geriatr
Jazaeri SZ, Joghataei MT, Jamali A, Taghizadeh G.
PMID: 41390609 [PubMed - as supplied by publisher]
Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases.
NPJ Parkinsons Dis
Fox SH, Luca DG, Postuma RB, Bhidayasiri R, Cardoso F, Kovacs GG, Katzenschlager R, Trenkwalder C.
PMID: 41390531 [PubMed - as supplied by publisher]
Resistant starch improves Parkinson's disease symptoms through restructuring of the gut microbiome and modulating inflammation.
Brain Behav Immun
Petrov VA, Schade S, Laczny CC, Hallqvist J, May P, Jäger C, Aho VTE, Hickl O, Halder R, Lang E, Caussin J, Lebrun LA, Schulz J, Unger MM, Mills K, Mollenhauer B, Wilmes P.
PMID: 41389850 [PubMed - as supplied by publisher]
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.
Lancet Neurol
Greenland JC, Dresser K, Cutting E, Donegan R, Bond S, Crisp SJ, Scott KM, Voysey ZJ, Holbrook J, Kahanawita L, Pal R, Camacho M, Peattie ARD, Spindler LRB, Hong YT, Fryer TD, Williams-Gray CH.
PMID: 41389828 [PubMed - indexed for MEDLINE]
The gut microbiome, systemic inflammation, and autoimmunity in Parkinson's disease.
Lancet Neurol
de Castro Fonseca M, Zanetti L, Fanourakis S, Sulzer DL, Mazmanian SK.
PMID: 41389810 [PubMed - indexed for MEDLINE]
Inter-effort recovery hypoxia did not mitigate acute treadmill effects in people with Parkinson's disease.
Parkinsonism Relat Disord
Kalva-Filho CA, Zampier VC, Orcioli-Silva D, Faria MH, Papoti M, Barbieri FA.
PMID: 41389475 [PubMed - as supplied by publisher]
Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024.
J Mol Med (Berl)
Isakovi, Athanassiadis A, Khubeis M.
PMID: 41389269 [PubMed - indexed for MEDLINE]
Yi Jin Jing Exercise Program Improves in Cognition, Sleep and Functional Mobility for Mild and Moderate Parkinson 's Disease: A Randomized Controlled Trial.
Exp Aging Res
Xiao C, Zhou F.
PMID: 41388828 [PubMed - as supplied by publisher]
Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's disease.
Alzheimers Dement
Mirza SS, Duff-Canning S, Mapstone M, Fox S, Black SE, Binns MA, Breen DP, Fishman KN, Grimes DA, Lang AE, Levine B, McLaughlin PM, Troyer AK, Masellis M, Marras C.
PMID: 41388800 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 55827
Page 1 of 2792
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy